2595 — GenFleet Therapeutics (Shanghai) Share News
0.000.00%
Last trade - 00:00- HK$10.66bn
- HK$8.73bn
- CNY130.27m
GenFleet hits over 3-week high as cancer drug makes progress on BTD list
Brief: GenFleet Therapeutics (Shanghai) Says GFH375 Combined With Cetuximab Placed On Proposed BTD List
HK-listed GenFleet rises most in a month on repurchasing shares
Brief: GenFleet Therapeutics (Shanghai) Reports Loss Of RMB220.17 Million For Six Months
GenFleet rises most in 4 weeks on progress of GFH375 in cancer treatment
Brief: Genfleet Therapeutics (Shanghai) Says GFH375 Advances To Registrational Phase III Study In China
Brief: GenFleet Therapeutics (Shanghai) To Place 13.6 Mln New H Shares At HK$34.69 Per Share
Brief: GenFleet Therapeutics (Shanghai) Approves H Share Repurchase Up To HK$350 Million
Brief: Genfleet Therapeutics (Shanghai) Says GFH375 Granted Breakthrough Therapy Designation By China's NMPA
Brief: Genfleet Therapeutics (Shanghai) Posts FY Loss RMB1.79 BLN
Brief: GenFleet Therapeutics (Shanghai) Says GFH375 Granted First Breakthrough Therapy Designation In China
China's Genfleet Therapeutics soars in Hong Kong debut